欧盟委员会正就赛诺菲公司提出的承诺方案公开征求意见，这些承诺旨在解决其可能存在的反竞争行为。该行为涉及针对特定脆弱患者群体的竞争对手流感疫苗。
此举源于欧盟对赛诺菲可能滥用市场支配地位的调查。调查焦点在于，赛诺菲是否采取了不正当手段，阻碍了针对高风险患者（如老年人或免疫力低下者）的竞争性流感疫苗的市场准入或推广。
赛诺菲已提交一系列承诺，试图消除欧盟的竞争担忧。欧盟委员会现邀请市场参与者、竞争对手及公众在指定期限内，对这些承诺措施能否有效恢复相关市场的公平竞争环境提出反馈。
欧盟监管部门强调，此次意见征集是评估承诺方案是否充分的关键步骤。若最终接受承诺，将具有法律约束力；否则，欧盟可能继续推进反垄断诉讼程序。此举旨在确保脆弱患者群体能够获得多样化的疫苗选择，并保障疫苗市场的良性竞争。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.